Apheresis and Bridging Therapy
ASCT+CD19/22 CART
Phase 2 other completed
Quick answer
Apheresis and Bridging Therapy for Large B-cell Lymphoma is a Phase 2 program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Large B-cell Lymphoma
- Phase
- Phase 2
- Modality
- other
- Status
- completed